Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Dashboard
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
Membership Levels
By The Numbers
Biologics
141 Articles Available
1
6
Can't find what you're looking for? Try our
advanced search
.
Expansion
WuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing
PR-M06-19-NI-054
Biological Materials
Keys to Successful Storage, Management and Transport of Biological Materials
PAP-Q2-2019-CL-035
Expansion
Polpharma Biologics: Building on Early Achievements
PAP-Q2-2019-CL-027
Customer Focus
Designing a Customer-Centric CDMO
PAP-Q2-2019-CL-003
Capacity Expansion
Biotechpharma to Expand Process Development and GMP Manufacturing Capacity to 5,000 L
PR-M04-19-NI-057
Formulation
Developing and Characterizing DPI Formulations for Biologics
PAP-Q1-2019-CL-002
Lifecycle Support
Speed and Customized Support from Gene to GMP Manufacturing
PAP-Q1-2019-CL-026
Financing
Entrada Therapeutics Raises $59 Million Series A to Advance Intracellular Biologics Platform
PR-M12-18-NI-081
Biologics
Rentschler Expands Capabilities in Biologics Contract Manufacturing
PR-M12-18-NI-012
Biologics Manufacturing
AGC Triples U.S. Biopharmaceutical Production Capacity
PR-M12-18-NI-066
FDA
XOSPATA® (gilteritinib) Available at Biologics by McKesson
PR-M12-18-NI-045
Gene and Cell Therapy
PPD Expands GMP Lab Testing Capabilities for Biologics
PR-M12-18-NI-035
Market Prediction
Global Autoinjectors Market to 2023 - High-Value Biologics Boosting Market Growth
PR-M11-18-NI-041
Appointment
Abzena Announces $20m Investment into Expansion of Integrated Biotherapeutics Offering (Biologics Drug Substance and ADC) and Makes Key Executive Appointment
PR-M11-18-NI-036
CDMO
Dedicated CDMO Services Meet Customer Needs in the Dynamic Biopharma Sector
PAP-Q3-18-CL-004
FDA Clearance
Inova Diagnostics Receives FDA Clearance for Test to Detect Antibodies to HMGCR
PR-M09-18-NI-031
Clinical Trial
BeiGene Initiates New Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab Combined with Chemotherapy as First-line Treatment for Patients with Advanced Squamous Non-Small Cell Lung Cancer in China
PR-M08-18-NI-115
Small Molecule
SwRI to host 2018 small molecule drug development workshop
PR-M08-18-NI-112
FDA Approval
Kyowa Kirin Announces FDA Approval of Poteligeo® (mogamulizumab-kpkc) for the Treatment of Mycosis Fungoides and Sézary Syndrome
PR-M08-18-NI-109
Biologics
Building a Biologics Business from the Ground Up
PAP-Q2-18-CL-008
FDA Approval
Grifols Achieves Key Milestone with FDA Approval of the New Consolidated Manufacturing Facility (CMF) for Production of Recombinant Proteins
PR-M08-18-NI-123
Biologics
New Method Developed for Stereoselective Synthesis of Biologic Drug Substances
PAO-M08-18-NI-011
Biosimilars
Another mAb Biosimilar on the Horizon in Europe
PAO-M06-18-NI-006
Biologic Candidates
Addressing Development Challenges for Complex Biologic Drug Candidates
PAP-Q2-18-CL-004
1
6
»
